LEADER 01843nam  2200409   450 
001 9910688358203321
005 20230624210451.0
035   $a(CKB)5400000000045796
035   $a(NjHacI)995400000000045796
035   $a(EXLCZ)995400000000045796
100   $a20230624d2019      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGlomerulonephritis and Nephrotic Syndrome /$fedited by Thomas Rath
210  1$aLondon :$cIntechOpen,$d2019.
210  4$dİ2019
215   $a1 online resource (xii, 124 pages) $cillustrations
311   $a1-83962-383-7 
320   $aIncludes bibliographical references.
330   $aChronic kidney disease is a worldwide disease affecting up to 4% of the population. In many cases, glomerulonephritis is the underlying disease leading to kidney failure. One hallmark of glomerulonephritis is proteinuria, which may in its most severe form lead to nephrotic syndrome. In seven chapters, this book puts light on different aspects related to the pathophysiology and clinical aspects of glomerulonephritis. In addition, chapters dealing with the importance of biomarkers in patients with glomerulonephritis will be beneficial for the open-minded reader. Nevertheless, new insights in renal rehabilitation in patients with chronic kidney disease will be provided.
606   $aGlomerulonephritis
606   $aNephrotic syndrome
606   $aOphthalmology
615  0$aGlomerulonephritis.
615  0$aNephrotic syndrome.
615  0$aOphthalmology.
676   $a616.612
702   $aRath$b Thomas G.
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688358203321
996   $aGlomerulonephritis and Nephrotic Syndrome$92046873
997   $aUNINA